Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Prepaid Assets (2021 - 2025)

Aligos Therapeutics (ALGS) has disclosed Prepaid Assets for 5 consecutive years, with $4.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets fell 3.61% year-over-year to $4.9 million, compared with a TTM value of $4.9 million through Dec 2025, down 3.61%, and an annual FY2025 reading of $4.9 million, down 3.61% over the prior year.
  • Prepaid Assets was $4.9 million for Q4 2025 at Aligos Therapeutics, up from $4.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $13.5 million in Q4 2021 and bottomed at $3.4 million in Q2 2023.
  • Average Prepaid Assets over 5 years is $6.1 million, with a median of $5.3 million recorded in 2023.
  • The sharpest move saw Prepaid Assets soared 75.83% in 2022, then crashed 59.58% in 2023.
  • Year by year, Prepaid Assets stood at $13.5 million in 2021, then plummeted by 43.79% to $7.6 million in 2022, then plummeted by 30.16% to $5.3 million in 2023, then dropped by 4.11% to $5.1 million in 2024, then decreased by 3.61% to $4.9 million in 2025.
  • Business Quant data shows Prepaid Assets for ALGS at $4.9 million in Q4 2025, $4.2 million in Q3 2025, and $4.9 million in Q2 2025.